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Frizzled genes encode a family of Wnt ligand recep-
tors, which have a conserved cysteine-rich Wnt bind-
ing domain and include both transmembrane and
secreted forms. Work by others has shown that
experimental perturbation of Wnt signaling results in
aberrant hair formation, hair growth, and hair struc-
ture. To date, however, there is no information on
the contribution of individual Frizzled proteins to
hair development. We now report that Frizzled-3
expression in skin is restricted to the epidermis and
to the developing hair follicle. Northern analysis on
total mouse skin mRNA revealed a single Frizzled-3
transcript of 3.7 kb. Reverse transcription±polymer-
ase chain reaction and in situ hybridization analysis
revealed Frizzled-3 expression in epidermal and hair
follicle keratinocytes. Frizzled-3 transcripts are ®rst
detected in discrete foci in the developing epidermis
of 13 d embryos and later in the hair follicle placodes
of 15 d embryos, suggesting a role for this Frizzled
isoform in follicle development. In 17 d embryos
and 1 d old newborn mice Frizzled-3 expression is
limited to suprabasal keratinocytes and is not seen in
pelage follicles until 3 d postpartum. In 7 d old neo-
natal skin, Frizzled-3 is expressed throughout the epi-
dermis and in the outer cell layers of hair follicles.
We have also identi®ed the mRNA encoding human
Frizzled-3 in epidermal keratinocytes and in the
HaCaT keratinocyte cell line. Human Frizzled-3
mRNA encodes a 666 amino acid protein with
97.8% identity to the mouse protein. The human
Frizzled-3 gene was mapped using a radiation-hybrid
cell line panel to the short arm of chromosome 8
between the markers WI-1172 and WI-8496 near the
loci for the Hypotrichosis of Marie Unna and Hairless
genes. Key words: chromosome mapping/gene expression/
Wnt signaling. J Invest Dermatol 116:940±946, 2001
G
enetic and functional studies have shown that
WNT, a secreted protein, initiates intercellular
signaling by binding to Frizzled (FZD), a seven-
pass transmembrane protein with features reminis-
cent of G-protein-coupled receptors (reviewed by
Wodarz and Nusse, 1998; Seidensticker and Behrens, 2000). Other
components of the WNT signaling pathway include Dishevelled,
the adenomatous polyposis coli gene product, Axin, glycogen
synthase kinase-3b (GSK3b), b-catenin, and the TCF/LEF family
of transcription factors. In the absence of a WNT signal, b-catenin
is phosphorylated by GSK3b and targeted for degradation via the
ubiquitin pathway (Seidensticker and Behrens, 2000). The
diminished levels of b-catenin result in TCF-mediated repression
of WNT target genes. In cells exposed to a WNT signal arriving at
the cell surface, Frizzled (upon binding the WNT ligand) acts
through Dishevelled to inactivate GSK3b. The lack of GSK3b
kinase activity results in increased levels of b-catenin and the
formation of a TCF/b-catenin complex in the nucleus, which then
acts as a transcriptional activator of WNT target genes
(Seidensticker and Behrens, 2000).
The Wnt/Frizzled signaling pathway has been found to operate
in a number of tissues during development including, the central
nervous system, the skeletal system, the gut, and the integument
(Wodarz and Nusse, 1998; Uusitalo et al, 1999; Seidensticker and
Behrens, 2000). It appears to be especially important in mediating
mesoderm±ectoderm instructions, such as occurs in kidney
epithelial induction, feather bud formation, teeth eruption, and
hair follicle development (van Genderen et al, 1994; Millar et al,
1999; Widelitz and Chuong, 1999). Aberrant signaling of this
pathway has been found to be associated with tumorigenesis and
certain inherited developmental disorders. Oncogenic mutations
have been found in the adenomatous polyposis coli gene product,
AXIN1 and b-catenin in colon, liver, skin (melanoma), and hair
tumors (Groden et al, 1991; Morin et al, 1997; Rubinfeld et al,
1997; Chan et al, 1999; Satoh et al, 2000). In addition, FZD9 has
been proposed as a candidate for the Williams±Beuren syndrome
because of its localization within a critical region found to be
deleted in this disorder (Wang et al, 1997).
Vertebrate homologs of the Drosophila Frizzled gene were ®rst
identi®ed in the rat (Chan et al, 1992) and later several Frizzled
genes were identi®ed in a screen of mouse, chicken, zebra ®sh, sea
urchin, and nematode sequences (Wang et al, 1996). More recently,
there has been a concerted effort to identify the human homologs
(Sagara et al, 1998; Tanaka et al, 1998). All Frizzled proteins share
the following structural features; a N-terminal signal peptide
followed by a cysteine-rich domain of 120 amino acids containing
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10 highly conserved cysteine residues, a variant linker region of 40±
100 amino acids, seven transmembrane segments and an intra-
cellular tail of variable sequence and size (Wang et al, 1996; Barnes
et al, 1998). The cysteine-rich domain is thought to mediate
binding to Wnt ligands whereas the C-terminal tail is predicted to
interact with Dishevelled (Wodarz and Nusse, 1998). Recently,
several Frizzled-related proteins have been identi®ed that contain a
cysteine-rich domain, but lack the transmembrane sequences
(Wodarz and Nusse, 1998). These secreted proteins are thought
to modulate Wnt signaling by acting as diffusible antagonists, but
their exact role remains to be determined.
A number of transgenic animal models have been produced that
perturb Wnt signaling in skin and hair follicles using keratinocyte-
speci®c promoters to drive the overexpression of wild-type or
mutant components of the pathway. Overexpression of Wnt3 in
the outer root sheath and basal layer keratinocytes, using the keratin
K14 promoter, resulted in a short hair phenotype with cyclical
balding due to hair shaft defects (Millar et al, 1999). A similar hair
phenotype but without the cyclical balding was produced by
overexpression of Dishevelled-2 using the same K14 promoter
(Millar et al, 1999). These phenotypic differences were attributed to
the ability of Wnt3, being a secreted protein, to regulate target
genes differentially in different cells by signaling through different
Frizzled receptors and different Dishevelled isoforms. Similarly,
K14-Lef1 mice also have abnormal vibrissa and pelage follicles
(Zhou et al, 1995), whereas Lef1 null mutant mice are born without
whiskers or body hair (van Genderen et al, 1994). In contrast,
overexpression of a mutant b-catenin (that is refractory to GSK3b
regulation) resulted in an increased number of developing follicles
and a predisposition to develop tumors resembling pilomatricomas
(Gat et al, 1998). Taken together, these studies underlie the
importance of the Wnt signaling pathway to hair follicle develop-
ment and hair growth.
A survey of Frizzled expression in adult mouse tissues using
RNase protection, and during embryonic development by mRNA
in situ hybridization, revealed distinct differences in tissue distribu-
tion of the different isoforms (Wang et al, 1996). Fzd3 transcripts
were noted to have a predominantly neuroneal distribution (Wang
et al, 1996) but close inspection of their in situ hybridization data
revealed marked cutaneous and vibrissa follicle expression. In this
study, we examined the expression of Fzd3 in skin during
embryonic and postnatal development.
MATERIALS AND METHODS
Cell culture, tissue isolation, and RNA extraction The HaCaT
human keratinocyte cell line was obtained from Professor N.E. Fusenig
(Boukamp et al, 1988) and cultured in Dulbecco's minimal Eagle's
medium supplemented with 10% fetal bovine serum, penicillin, and
streptomycin (Gibco, Melbourne, Victoria, Australia). Human epidermis
was carefully removed from neonatal foreskins after 24 h incubation in
2.5% dispase (Sigma, Sydney, NSW, Australia)/phosphate-buffered saline
at 4°C and was a gift from Dr N.A. Saunders (University of
Queensland). Newborn mouse skin was removed from killed Swiss
outbred pups that were between 24 and 48 h old. The skin was rinsed in
20 mM Tris (pH 7.5) containing 20 mM Vanadyl Ribonuclease
Complex (Gibco), incubated at 65°C for 42 s in the same buffer and the
dermal and epidermal layers separated immediately (Roop et al, 1983).
For the developmental series, timed matings of Swiss outbred mice were
used to obtain day 12±18 mouse embryos and 1, 3, and 5 d old newborn
mice. Total RNA was extracted from cultured cells and skin samples
using TRI-reagent according to the manufacturer's instructions
(Molecular Research Center Inc, Cincinnati, OH).
Northern blot analysis Twenty-®ve micrograms of total RNA from
mouse brain and 50 mg from mouse skin were electrophoresed on a
denaturing 1.2% agarose gel containing 3% formaldehyde, transferred to
Hybond-N nylon membrane (Amersham Sydney, NSW, Australia) by
capillary diffusion and stabilized by ultraviolet cross-linking (Sambrook et
al, 1989). Polymerase (PCR) ampli®ed Fzd3 and GAPDH coding probes
were labeled with a-32P-deoxycytidine triphosphate by random primer
labeling using the RTS RadPrime DNA labeling system (Gibco). The
353 bp Fzd3 probe contained exon 4 sequences and was generated using
primers MFZD3Q5 and MFZD3Q6 (Table I). The membranes were
hybridized with 25 ng of labeled DNA overnight at 42°C, washed, and
exposed to X-ray ®lm using a single intensifying screen. RNA quality
was determined by visualization of the ethidium bromide stained gels
before transfer. Northern blots were stripped and then hybridized with a
GAPDH probe to determine mRNA loading levels.
Reverse transcriptase±PCR and RACE±PCR Five micrograms of
total RNA was used as the template for ®rst strand complementary
(cDNA) synthesis using Superscript II Reverse Transcriptase (Gibco).
One microgram of the reverse transcriptase reaction was ampli®ed using
hot start PCR (94°C, 2 min), followed by 40 cycles each consisting of a
denaturation step (94°C, 30 s), an annealing step (58°C, 30 s), and an
elongation step (72°C, 30 s). After ampli®cation, samples were
electrophoresed through an agarose gel (1.6% wt/vol) in the presence of
ethidium bromide and visualized under ultraviolet light. PCR products
were gel-puri®ed (QIAEX II Agarose Gel Extraction Kit, QIAGEN,
Melbourne, Victoria, Australia) and sequenced using ABI Prism BigDye
Table I. Sequences of oligonucleotide primers
Name Direction Sequence Locationa
MFZD3Q3 Forward TCATGGAGATGTTTGGTG 650±667 mouse
MFZD3Q5 Forward GACAATATTAGTGGCGTG 1375±1392 mouse
MFZD3Q6 Reverse ATCTGAGTAACCTGGTAC 1727±1710 mouse
MFZD3Q7 Reverse GAAGCATGTGTGGATGTC 1994±77 mouse
MFZD3Q12 Reverse ACGGAATCTTGTGACGTC 1008±991 mouse
HFZD3Q1 Reverse TACTGCATTCCATATCTTCAG 451±431 human
HFZD3Q2 Forward GATTTCAATCATTTGCCTCTC 690±710 human
HFZD3Q3 Forward RCCNATHACNYTNAGRATGTG 153±173 human
HFZD3Q4 Reverse NKCYTCDATNACNCGRTTCAT 2049±2029 human
HFZD3Q5 Reverse CAGAAGATTAGGCATGAAGGT 216±196 human
HFZD3Q6 Forward ACGACATAGCAGCATCAGAGA 1965±85 human
HFZD3Q7 Forward CATAGTAGTTCTCATCGGCTC 1933±53 human
HFZD3Q8 Reverse CAAATCTGGCACTCACAACCT intron 4 human




aSequence numbering in bp from the ®rst nucleotide of the start codon.
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chemistry and the ABI Prism 377 Sequencer (Perkin-Elmer, Melbourne,
Victoria, Australia).
Identi®cation of mouse Fzd3 transcripts by reverse transcriptase±PCR
employed primers MFZD3Q5 and MFZD3Q7 (Table I), which span
introns 5 and 6, but produce a product of 620 bp from a cDNA
template. Human FZD3 cDNA was obtained by amplifying a random
primed template using mouse-speci®c primers MFZD3Q3 and
MFZD3Q12 (Table I). The resulting 359 bp sequence was extended
using speci®c human and degenerate primers HFZD3Q1, HFZD3Q2,
HFZD3Q3, and HFZD3Q4. The sequence was completed using 5¢ and
3¢ RACE±PCR. For 5¢ RACE±PCR, we used a cDNA template that
was generated using the primer HFZD3Q1 (Table I) and C-tailed using
terminal transferase (Gibco) according to the original protocol (Frohman
et al, 1988). PCR was performed using the RACE anchor and adapter
primers (RACEQ1 and RACEQ2) and the FZD3-speci®c nested primer
HFZD3Q5. The 3¢ RACE±PCR experiments used a cDNA template
primed with an oligo-dT-adapter primer RACEQ3. PCR was then
performed using RACEQ2 and HFZD3Q7 and the product reampli®ed
with RACEQ2 and the FZD3-speci®c nested primer HFZD3Q6. PCR
conditions were as listed above.
In situ hybridization Mouse tissues were immediately excised from
animals killed by cervical dislocation and ®xed for 4 h in 4%
paraformaldehyde in phosphate-buffered saline at 4°C, prior to
embedding in paraf®n. In situ hybridization with digoxigenin (DIG) -
labeled cRNA probes was performed using a modi®cation of the
protocol described by Tohyama et al (1994). After deparaf®nizing
(xylene) and rehydration (100±50% ethanol then phosphate-buffered
saline), sections were digested for optimal probe penetration with
proteinase K (10 mg per ml) for exactly 10 min at 37°C. To minimize
nonspeci®c background signals, sections were acetylated at room
temperature for 15 min, followed by prehybridization for 2 h at 55°C.
The sections were then hybridized with sense or anti-sense labeled DIG
probes at 55°C for 16 h in the presence of 50% formamide, 4 3 sodium
citrate/chloride buffer, 1 3 Denhardt's, 50% dextran sulfate, and 50 mg
per ml yeast tRNA. T7 and Sp6 polymerases were used to synthesize
sense and anti-sense transcripts labeled with DIG (Roche Diagnostics,
Sydney, NSW, Australia) from a plasmid containing Fzd3 3¢ noncoding
sequences. The 328 bp 3¢ noncoding template was generated by RsaI
and BglII digestion of a mouse Fzd3 cDNA clone and the product
ligated into pSP70 (Promega, Sydney, NSW, Australia). Probe labeling
was determined and concentration adjusted to ensure equal amounts of
label for each probe was present in the hybridization step. Following
hybridization, unbound cRNA probes were removed from the sections
by an initial wash with 2 3 sodium citrate/chloride buffer/50%
formamide solution, digestion with 20 mg per ml RNase A at 37°C for
15 min, and a ®nal wash with 1 3 sodium citrate/chloride buffer/50%
formamide at 55°C for 10 min. The sections were then incubated for
30 min at reverse transcription in 5% normal heat inactivated sheep
serum in 100 mM Tris±150 mM NaCl solution, rinsed then incubated
for a further 60 min in 0.5% DIG blocking reagent (Roche Diagnostics)
in Tris±NaCl at reverse transcription for 60 min. The bound probes
were reacted with anti-DIG antibody conjugated to alkaline phosphatase
for 60 min and visualized using the standard color development solution
of BCIP (5-bromo-4-chloro-3-indoyl phosphate) and nitroblue
tetrazolium. Endogenous alkaline phosphatase activity was blocked by
the addition of freshly prepared levamisole (5 mM) to the chromogenic
reagent solution. The color development reaction was stopped by
immersing the slides in 100 mM Tris-10 mM EDTA pH 8.0. Strong
gene expression produces a deep purple±brown color whereas lighter
tones of pink±brown indicate lower levels of expression. Photomicro-
graphy was performed with a Zeiss Axiophot photomicroscope.
Chromosomal localization The Genebridge 4 Radiation Hybrid
DNA panel (U.K. HGMP Resource Center) was kindly provided by
Professor B. J. Wainwright (University of Queensland). Two PCR
primers (Table I), HFZD3Q8 (reverse) and HFZD3Q9 (forward), were
designed from intron 4 sequences of human FZD3. The primers
ampli®ed the expected 220 bp product from human genomic DNA, but
not from hamster genomic DNA (data not shown). The 220 bp product
was then ampli®ed using the Genebridge 4 radiation hybrid panel DNA
(Gyapay et al, 1996), producing the following vector data: 0000000-
10100100000000001110111012010001211000110001000000000011001-
001010011011001121000000110. Localization was determined using the
rhmapper software of the WICGR Mapping Service (http://carbon.
wi.mit.edu:8000/cgi-bin/contig/rhmapper.pl).
RESULTS AND DISCUSSION
Characterization of Fzd3 expression in skin We used a
343 bp probe generated from the coding region of Fzd3, which has
little homology, as determined by sequence alignment, to the other
Frizzled genes. This probe detected a single band of 3.7 kb on a
northern blot of mouse skin RNA (Fig 1), con®rming the earlier in
situ data showing Fzd3 expression in skin (see ®g 8 in Wang et al,
1996). The 3.7 kb band is of the size predicted for the Fzd3
transcript with 2 kb of coding and 1.7 kb of noncoding sequences
(Wang et al, 1996). Interestingly, three bands (3.7, 4.0, and 8.0 kb)
were detected in total mouse brain RNA (Fig 1). The identity of
the 4.0 and 8.0 kb bands was not determined, but these may
represent either alternatively spliced variants of Fzd3 or unknown
transcripts that are homologous to the probe.
In order to characterize Fzd3 expression in skin further we
performed reverse transcriptase±PCR on dermal and epidermal
RNA. This analysis revealed that Fzd3 expression is con®ned to the
epidermis of neonatal mouse skin (Fig 2). We then used in situ
hybridization to examine Fzd3 expression during skin development
from day 11 postcoitus to day 7 neonates (Fig 3). Hybridization
signals using the Fzd3 riboprobe were ®rst detected in day 13
Figure 1. Northern analysis of mouse Fzd3 transcripts. A mouse
FZD3 probe was hybridized to immobilized total RNA isolated from
7 d old neonatal mouse skin and brain. A single band of 3.7 kb was
identi®ed in mouse skin RNA and three bands (8.0 kb, 4.0 kb, and
3.7 kb) were identi®ed in mouse brain RNA. The size of these bands
was estimated from their migration relative to that of the 28S and 18S
rRNA. The same ®lter was hybridized with a GAPDH probe as a
control (bottom panel).
Figure 2. Determination of mouse Fzd3 expression by reverse
transcriptase±PCR. Reverse transcriptase±PCR was performed on
mRNA isolated from epidermal (E), dermal (D), and brain (B) tissue
extracts from newborn mice (less than 48 h old). The control lane
(H2O) shows the result of a reaction without mRNA. The ®delity of the
mRNA was con®rmed by northern analysis using a GAPDH probe
(bottom panel).
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postcoitus epidermis just prior to hair follicle placode development
(Fig 3b). The signal appeared in discrete regions within the
intermediate cell layer and periderm, but not in the basal layer of
developing back skin. By day 15 postcoitus the riboprobe was
clearly concentrated over follicle placodes and more advanced
follicle plugs (Fig 3c). In the interfollicular regions the signal
appears to be greatest in the cells above the basal layer. Within the
developing plugs Fzd3 expression is greatest in the distal portion of
the plug and in the adjacent epidermis. At day 15 the follicle plugs
¯atten at the proximal end prior to formation of the dermal papilla.
The level of Fzd3 expression in the proximal portion of the plug
and the adjoining dermal condensate is substantially less than the
rest of the follicle plug. Expression of Fzd3 was also readily seen in
developing day 15 postcoitus vibrissa follicles (Fig 3d), but in
contrast to back skin at the same developmental stage, Fzd3
transcripts were present throughout the basal layer of snout
epidermis. At day 17 postcoitus, Fzd3 expression is limited to the
spinous layer and periderm in the head and back skin regions, with
the basal layer and developing follicles being devoid of chromo-
genic signal (Fig 3e). Similarly, in day 1 postpartum back skin
sections Fzd3 expression is mainly con®ned to the suprabasal cells
of the interfollicular epidermis, although low-level expression was
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occasionally observed in basal cells (Fig 3f). Day 1 postpartum
pelage follicles were also devoid of signal unlike the strong
expression pattern seen in day 7 postpartum hair follicles (Fig 3g±
j). In day 7 postpartum back skin Fzd3 expression was seen
throughout the living cell layers of the epidermis, including the
basal layer and in the keratinocytes forming the neck of the follicle
(Fig 3h, j). The sebaceous glands did not show any appreciable
Fzd3 expression (Fig 3h). In the follicle proper, the highest levels
of Fzd3 expression were found in the companion cell layer and in
Henle's layer of the inner root sheath (Fig 3g, i). Lower levels of
Fzd3 expression were noted in the progenitor cells of the follicle
bulb, but no expression was observed in the dermal papilla or hair
Figure 3. Localization of mouse Fzd3 transcripts in embryonic and neonatal skin. Consecutive paraf®n cross sections were reacted with a
digoxigenin-labeled anti-sense riboprobe corresponding to the coding region of the mouse Fzd3 gene. (a) Fzd3 transcripts were not detected in day 11
postcoitus mouse back skin, where a relatively undifferentiated epidermis overlays the dermis and no hair follicles are present (stage 0). (b) Day 13
postcoitus mouse back skin showing discrete regions of Fzd3 expression in the intermediate and periderm layers (stage 1). (c) Day 15 postcoitus mouse
back skin with strong expression in the follicle placode and overlying epidermis (stage 2 prepapilla follicles). (d) Day 15 postcoitus snout skin showing
strong Fzd3 expression in developing vibrissa follicles (arrows). (e) Day 17 postcoitus Fzd3 expression is con®ned to the spinous layer, granular layer,
and periderm in back skin epithelium, whereas the basal layer and developing follicle plug are devoid of the chromogenic signal (stage 3 follicles). (f)
Day 1 neonate back skin showing Fzd3 expression in the epidermis, but not in the developing pellage follicles (stage 7 follicles where the tips of the
hairs have reached the hair canals and sebaceous cells appear in the sebaceous gland swellings). (g, i) Day 7 postpartum back skin section showing strong
Fzd3 expression in the companion cell layer, inner root sheath, and progenitor cells of these layers in the upper bulb. (h, j) Seven day old neonatal
back skin showing strong Fzd3 expression in the keratinocytes of the epidermis and the neck of the follicle. (i, j) A single pelage follicle showing Fzd3
expression from bulb to epidermis (stage 10). Note that the hair ®ber lacks Fzd3 expression. Digoxigenin-labeled sense probes corresponding to the 3¢
noncoding region of Fzd3 did not elicit a chromogenic signal in the tissues described above (data not shown). Stages of mouse pelage follicle
development correspond to those described by Hardy (1949). Morphologic stages of mouse skin development correspond to those described by Sengel
(1976). Abbreviations: basal layer (bl), companion cell layer (ccl), corni®ed layer (cl), dermis (d), dermal condensate (dc), dermal papilla (dp), epidermis
(ep), ®ber (f), follicle plug (fp), granular layer (gl), hair follicle (hf), inner root sheath (irs), outer root sheath (ors), periderm (p), sebaceous gland (sg),
spinous layer (sl). Scale bars: (a±c, e) 50 mm; (d, f±j) 100 mm.
Figure 4. Comparison of the primary
structures of human (hFZD3), mouse
(mFzd3), and Xenopus (xFzd3) Frizzled-3. The
amino acid sequences were aligned using the
ClustalW alignment tool (ANGIS; http://www.
angis.org.au). Sequence homology comparison of
the predicted human peptide revealed 97.8% and
88.1% identity with the mouse and Xenopus
proteins, respectively. The 10 highly conserved
cysteine residues of the putative WNT binding
domain are indicated in reverse lettering and
amino acid differences from the human protein
are indicated by gray shading. The seven
transmembrane domains (TM) are underlined.
The human FZD3 mRNA sequence has been
deposited in GenBank under the accession
number AY005130.
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®ber (Fig 3g, i). In the more distal portions of the follicle, Fzd3
expression was evident in outer root sheath cells and was especially
strong in cells lining the neck of the follicle (Fig 3j).
Expression of Fzd3 in pelage follicles was ®rst observed in stage 1
primary follicles and the adjacent thickened epidermis (Fig 3c), yet
surprisingly was no longer evident in stage 3 follicles (Fig 3e). Even
by stage 6 (Fig 3f), which heralds the formation of the hair shaft,
there is no obvious Fzd3 expression in follicular cells. It is not until
stage 8 (day 3 postpartum), when the morphogenesis of the oldest
pelage follicles is complete and there is an accelerated period of
®ber production (Sengel, 1976) that a second phase of Fzd3
expression in the follicle was observed (data not shown). It remains
to be determined why Fzd3 expression is repressed in developing
pelage follicles between day 17 postcoitus and day 1 postpartum
only to be induced again at later stages of follicle development;
however, this observation suggests that Fzd3 is recruited for two
separate developmental events. The appearance of Fzd3 transcripts
in keratinocytes forming the hair placodes suggests a role for this
Frizzled isoform in the initial stages of follicle development,
whereas the expression of Fzd3 in the companion cell layer, inner
root sheath, and outer root sheath of mature follicles suggests a role
in follicle growth and/or maintenance. Interestingly, the localiza-
tion of Fzd3 expression in interfollicular keratinocytes was also seen
to change during back skin development. Although the reasons for
this switch in expression are unknown, the presence of Fzd3
transcripts in all layers of day 7 postpartum epidermis suggests a part
for Wnt signaling in the maintenance of this tissue as well. The
determination of the role of this isoform in skin will ultimately
require tissue-speci®c ablation of Fzd3 expression together with a
complete survey of all Frizzled gene expression in this tissue.
PCR-mediated cloning of human FZD3 When we initiated
this study, there were two human genes (FZD3, FZE3) whose
nomenclature suggested that they were orthologs of mouse Fzd3.
The previously named FZD3 gene, which was mapped to 7q11.23
in a region deleted in Williams±Beuren syndrome, has since been
renamed FZD9 on the basis of its expression pattern and homology
with mouse Fzd9 (Wang et al, 1997, 1999). The FZE3 gene was
originally identi®ed in a screen of Frizzled genes expressed in
oesophageal carcinoma and subsequently shown to be almost
identical to FZD7 (Sagara et al, 1998; Tanaka et al, 1998). As the
sequence of the human homolog was unavailable, we used two
mouse Fzd3 speci®c primers that had high sequence identity with
the Xenopus homolog to amplify related cDNA sequences from the
HaCaT human keratinocyte cell line and from foreskin epidermis.
The resulting 359 bp fragment was sequenced and the adjacent
sequences were ampli®ed using two primers designed from the
internal sequence paired with degenerate primers (see Materials and
Methods). RACE±PCR was used to complete the human cDNA
sequence, which contains a 2001 bp open reading frame encoding a
666 amino acid peptide (Fig 4). Sequence homology comparison
of the predicted peptide revealed 97.8% and 88.1% identity with
the mouse and Xenopus proteins, respectively, con®rming the
sequence as human FZD3. Most of the amino acid differences
between the mouse and human proteins are in the leader peptide.
This is also true for a comparison between the mammalian and frog
proteins but signi®cant differences are also seen within the putative
linker peptide. While this manuscript was in preparation, two other
human FZD3 sequences were deposited in the DNA databases
(accession nos AJ272427and AB039723) together with published
reports on the cloning of FZD3 cDNA (Kirikoshi et al, 2000; Sala
et al, 2000). The primary sequence of human FZD3 isolated from
keratinocytes is identical to these other sequences.
Chromosomal mapping of the human FZD3 gene The
human gene was mapped using intron 4 speci®c primers in a PCR
screen of the Genebridge 4 radiation hybrid panel (Gyapay et al,
1996). Analysis of the resulting vector data by the RHMAPPER
program unambiguously assigned the gene to the short arm of
chromosome 8 (8p21) between STS markers WI-1172 and WI-
8496 (Fig 5). Our ®nding is in agreement with the recent mapping
of FZD3 to chromosome 8p21 using ¯uorescence in situ
hybridization or in silico techniques (Kirikoshi et al, 2000; Sala et
al, 2000), and is consistent with the localization of mouse Fzd3 to
chromosome 14 (Wang et al, 1996).
The chromosomal region 8p21 contains at least two loci that are
relevant to hair follicle development and/or growth, the Hairless
(HR) gene and the gene for hypotrichosis of Marie Unna (HMU).
Mutations in HR were recently identi®ed in large kindreds with
recessive congenital atrichia where affected individuals show almost
complete hair loss (Ahmad et al, 1998; Zlotogorski et al, 1998;
Sprecher et al, 1999). HMU is an autosomal dominant hair loss
disorder with early onset (Unna, 1925). The gene responsible for
HMU has not yet been identi®ed but has been mapped to a 2.4 cM
region telomeric to HR (van Steensel et al, 1999). Sequence analysis
of the HR gene in affected HMU individuals has excluded HR as a
candidate gene for this disorder (van Steensel et al, 1999; Sreekumar
et al, 2000; Lefevre et al, 2000). Interestingly, mice that are de®cient
in Lef-1 (van Genderen et al, 1994), which lies downstream of
Frizzled in the Wnt signaling pathway, exhibit phenotypes similar
to atrichia and HMU patients. Given the expression pattern of
FZD3, we predict that mutations in this gene may also result in
similar hair defects.
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Figure 5. Representation of human chromosome 8 and the
physical map of its short arm in the neighborhood of the FZD3
gene. The FZD3 gene was mapped using the Genebridge 4 radiation
hybrid panel. Distances between markers and the FZD3 locus are shown
in cR.
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